Cancer Patients Using Alternative Medicine Keep Oncologists in Dark

Key points
- Many cancer patients undergoing radiation treatment or chemotherapy keep their use of complementary or alternative medicines secret from their oncologists, an omission that could compromise treatment, according to a survey.
- A survey of 273 patients at Philadelphia cancer clinics and Internet responders found that 48% of patients hedge their bets with alternative or complementary products, and about 75% of them do not divulge this to their doctors.
- Of the radiation patients, 35% used complementary or alternative medicines, researchers reported at the American Society for Therapeutic Radiology and Oncology meeting here.
- The study included 142 patients getting radiation therapy for either breast or Prostate cancer, and 131 chemotherapy patients, said Neha Vapiwala, M.D., a radiation oncology resident at the University of Pennsylvania in Philadelphia.
Many cancer patients undergoing radiation treatment or chemotherapy keep their use of complementary or alternative medicines secret from their oncologists, an omission that could compromise treatment, according to a survey.
A survey of 273 patients at Philadelphia cancer clinics and Internet responders found that 48% of patients hedge their bets with alternative or complementary products, and about 75% of them do not divulge this to their doctors.
Of the radiation patients, 35% used complementary or alternative medicines, researchers reported at the American Society for Therapeutic Radiology and Oncology meeting here. Of those receiving chemotherapy, 65% used complementary or alternative products.
The study included 142 patients getting radiation therapy for either breast or Prostate cancer, and 131 chemotherapy patients, said Neha Vapiwala, M.D., a radiation oncology resident at the University of Pennsylvania in Philadelphia.
"When we give patients radiation therapy, we want the radiation to create free radicals that destroy tumor cells," Dr. Vapiwala said in a poster presentation. "But herbal medications such as saw palmetto and St. John's Wort contain antioxidants that may prevent what we want the radiation to accomplish."
Dr. Vapiwala said that all patients undergoing radiation therapy are advised to stop taking all alternative or complementary medications except for a once-daily standard vitamin pill. They are specifically asked to stop high doses of vitamins. "We really don't know what these products do to our patients undergoing radiation, so we think the best answer - until they are thoroughly studied - is not to use them," she said.
The survey respondents suggested that they used the non-prescription products as a cost-effective means of treating their cancer. On average, patients used two different products, with vitamins, herbal supplements, and botanical supplements being the most common.
According to Dr. Vapiwala, patients who used these products tended to have a higher educational level, reflecting possible higher income to purchase the supplement, as well as access to the Internet and other publications.
It's important for doctors to know about their patients' use of complementary or alternative medicines and to understand patients' reasons for using them, Dr. Vapiwala said. In this way, physicians can better tailor treatment regimens and improve patients' quality of life.
Dr. Vapiwala advised doctors to be more open with patients about these medicines so the patients will discuss them in detail. Also, she added, ask patients about the medications throughout the treatment period. "A one-time question is not enough."
"This is a problem most of us don't know how to deal with," said Gregory Swanson, M.D., an associate professor of radiation oncology and urology at the University of Texas at San Antonio. "You name a product, and some of our patients have taken it."
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNCCS pioneers new drug regimen which reduces toxicities for renal cancer patients
A study led by the Genitourinary (GU) oncology team at National Cancer Centre Singapore (NCCS) has revealed conclusive results in reducing toxicities for Asian patients with metastatic renal cell carcinoma (mRCC) or…
19 March 2015
NewsLiver-sparing operation associated with higher survival rates in cancer patients
A surgical approach in which a surgeon removes less than a lobe of the liver in a patient undergoing an operation for liver cancer is associated with lower mortality and complication rates, according to new study…
13 March 2015
NewsPalbociclib shows promise in patients with hormone-resistant breast cancer
Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast…






